Ensofy is an emerging player in the intersection of AI and healthcare, founded in 2021 and headquartered in Georgia. The company's focus is on revolutionizing mental health management by utilizing proprietary AI-based vocal biomarkers to identify mental health conditions efficiently and non-invasively.
Ensofy's slogan, "Mental Health Management using Voice + AI," underscores their commitment to enhancing the capabilities of healthcare providers through innovative technology. Their solution aims to address traditional pain points in mental health diagnostics, offering a faster and less intrusive alternative.
In terms of investment, Ensofy secured a Pre Seed Round investment on 02 August 2022, with XLerateHealth leading the round. This early financial backing demonstrates investor confidence in their disruptive approach and potential for growth in the health and wellness sector.